BIK Blocking Peptide
-
Catalog number3703BP-50
-
PricePlease ask
-
Size50 μg
-
-
Antibody TargetBIK
-
AccessionQ13323
-
Gene ID638
-
AppearanceColorless liquid
-
Concentration0.2 mg/ml
-
Formulation50 µg (0.2 mg/ml) in phosphate buffered saline (PBS), pH 7.2, containing 0.1% BSA and 0.02% sodium azide.
-
Application UsageThe peptide is used for blocking the antibody activity of BIK (Cat.# 3703-100). It usually blocks the antibody activity completely in Western blot analysis by incubating the peptide with equal volume of antibody for 30 minutes at 37°C.
-
Storage Temp-20 °C
-
Shippinggel pack
-
Shelf Life12 months
-
Western Blot WBVerified
-
HandlingThe peptide solution should be gently mixed before use.
-
Research UseFor Rersearch Use Only! Not to be used in humans.
-
TestYou can block the antibody by the specific target amino acid sequence of peptide.
-
Propertiesblocking peptide
-
DescriptionPeptides short amino acid chains or epitopes or blocking antagonists. The shortest peptides are dipeptides, consisting of 2 amino acids joined by a single peptide bond, followed by tripeptides, tetra peptides, ... till polypeptides that are long, continuous, and unbranched synthetic peptide chains. These biological oligomers and polymers can be Solid-phase peptide synthesis (SPPS), or in continue produced for custom peptide synthesis projects. The High-efficiency solid phase peptide synthesis (HE-SPPS) is give very low production costs.
-
Gene target
-
Gene symbolBIK
-
Short nameBIK Blocking Peptide
-
Techniqueblocking peptide, Blocking, peptide, blocking peptides, Biovision made this blocking amino acid sequence or peptide to block the gene target in a volume of 1. For western blot it is often requested to block your antibody and to see the band of the analyzed protein disappear. This is called a negative control by blocking the WB antibody. peptides
-
Alternative nameBCL2-interacting killer (apoptosis-inducing) inhibiting short protein sequence
-
Alternative techniquecontrol, peptides
-
Alternative to gene targetBCL2-interacting killer (apoptosis-inducing), BIP1 and BP4 and NBK, BIK and IDBG-10395 and ENSG00000100290 and 638, BH domain binding, Plasma membranes, Bik and IDBG-168304 and ENSMUSG00000016758 and 12124
-
Gene info
-
Identity
-
Gene
-
Long gene nameBCL2 interacting killer
-
Synonyms gene name
- BCL2-interacting killer (apoptosis-inducing)
-
Synonyms
-
Synonyms name
-
GenBank acession
-
Locus
-
Discovery year1996-10-26
-
Entrez gene record
-
Pubmed identfication
-
RefSeq identity
-
Classification
- BCL2 homology region 3 (BH3) only
-
VEGA ID